Literature DB >> 17629611

Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients.

Jorge Huguet1, Vanesa Monllau, Sergi Sabaté, Oscar Rodriguez-Faba, Ferran Algaba, Juan Palou, Humberto Villavicencio.   

Abstract

OBJECTIVES: We evaluated incidence, diagnosis, risk factors, and outcome of urethral recurrences (URs) following radical cystectomy in men with bladder urothelial carcinoma (UC).
METHODS: Between 1978 and 2003, a total of 729 male patients underwent radical cystectomy for UC. We determined UR presentation mode and diagnosis. UR was analysed by multivariate analyses according to clinical and pathological risk factors. We evaluated the relative influence of bladder versus urethral pathology on overall survival.
RESULTS: A total of 34 URs (4.6%) were identified. Previous history of non-muscle-invasive bladder cancer (NMIBC) (p=0.005), NMIBC pathological subgroup (pTis, pTa, pT1) (p=0.038) and prostate tumor involvement (p=0.0001) in cystectomy specimens were independent predictors of UR. URs developed in 5 (2.2%) of 219 cases with orthotopic diversion and in 29 (5.6%) of 510 with cutaneous diversion (p=0.073). The difference could be explained by patient selection. Cutaneous diversion group had more patients at risk of UR: more cases with prostate tumor involvement (p=0.026) and with a history of NMIBC (p=0.009). Neither bladder nor urethral pathology showed any superiority as a predictor of overall survival.
CONCLUSIONS: Previous history of NMIBC, and also NMIBC and prostate tumor involvement in cystectomy specimen were predictors of UR. The lower incidence of UR in patients with orthotopic diversion could be a result of patient selection. Bladder tumor, UR, and even an upper urinary tract tumor could have been the cause of death in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17629611     DOI: 10.1016/j.eururo.2007.06.045

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  Current management of muscle-invasive bladder cancer.

Authors:  G Sancho; P Maroto; J Palou
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

2.  Management of the urethra in urothelial bladder cancer.

Authors:  Androniki Kanaroglou; Bobby Shayegan
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 3.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

4.  Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  E Compérat; J R Srigley; F Brimo; B Delahunt; M Koch; A Lopez-Beltran; V Reuter; H Samaratunga; J H Shanks; T Tsuzuki; T van der Kwast; M Varma; F Webster; D Grignon
Journal:  Virchows Arch       Date:  2020-01-08       Impact factor: 4.064

Review 5.  Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.

Authors:  Georgios Gakis; Peter C Black; Bernard H Bochner; Stephen A Boorjian; Arnulf Stenzl; George N Thalmann; Wassim Kassouf
Journal:  Eur Urol       Date:  2016-10-06       Impact factor: 20.096

6.  Outcomes of patients undergoing concurrent radical cystectomy and nephroureterectomy: A single-institution series.

Authors:  Gianpaolo P Carpinito; Grayden S Cook; Aaron N Tverye; Samuel A Gold; Yair Lotan; Vitaly Margulis; Jeffrey M Howard
Journal:  Can Urol Assoc J       Date:  2022-07       Impact factor: 2.052

7.  Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Dong Hyeon Lee; Wan Song
Journal:  Cancer Manag Res       Date:  2020-08-03       Impact factor: 3.989

8.  Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients.

Authors:  Xinyuan Li; Wuwan Wang; Gongmin Zhu; Weiyang He; Xin Gou
Journal:  Oncotarget       Date:  2017-12-19

9.  Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?

Authors:  Günter Niegisch; Christina Hulsbergen-van de Kaa; Martine Ploeg; Kees Hendricksen; J Alfred Witjes
Journal:  Bladder Cancer       Date:  2015-04-30

10.  Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10-year, single center experience.

Authors:  Nozomi Hayakawa; Nobuyuki Kikuno; Hiroki Ishihara; Osamu Ryoji; Kazunari Tanabe
Journal:  Springerplus       Date:  2015-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.